MCK vs SCM · P/E 20, rev $403.43B vs P/E 10, rev $97.8M
McKesson Corporation (MCK) versus Stellus Capital Investment (SCM) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Stellus Capital Investment (SCM) is a asset management company listed on NYSE.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported SCM revenue for 2025-12-31 was $97.8M. Net income was $27.0M. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. SCM currently screens at market cap $244.6M and trailing P/E 10.2.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. SCM currently screens at market cap $244.6M and trailing P/E 10.2.
Not investment advice. Open the MCK and SCM stock pages for the full models.
Not investment advice.